Skip to main content

Table 1 Chromatographic conditions

From: Stability-indicating RP-HPLC method development and validation for simultaneous estimation of telmisartan and rosuvastatin calcium in bulk and in tablet dosage form

Parameters

Results

Type of system

HPLC with UV detector or equivalent

Pump mode

Isocratic

Mobile phase

10 mM phosphate buffer with 1.1 g octane-1-sulfonic acid sodium salt having pH 2.5 (adjusted with 5% OPA) and Acetonitrile (500:500, v/v)

Column

Oyster ODS3 (5 µm, 4.6 × 150 mm) P/N: S670153 (Make: Merck & Co.)

Injection   volume

20 µL

Run time

9 min

Flow rate

1.0 mL/min

Detection

242.0 nm

Column temperature

Ambient (about 25 °C)

Blank

Diluent